Roche, Chiasma partner to develop, commercialise Octreolin

Roche and Chiasma have partnered to develop and commercialise Octreolin, an investigational oral regimen for acromegaly and neuroendocrine tumours.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news